🇺🇸 FDA
Pipeline program

K0706

CLR_18_06

Phase 2 small_molecule terminated

Quick answer

K0706 for Early Parkinson Disease is a Phase 2 program (small_molecule) at Advanced Accelerator Applications with 1 ClinicalTrials.gov record(s).

Program details

Company
Advanced Accelerator Applications
Indication
Early Parkinson Disease
Phase
Phase 2
Modality
small_molecule
Status
terminated

Clinical trials